In the CheckMate 915 study, it has been possible to see that in the adjuvant treatment of high-risk melanoma in stage IIIA-D or resected stage IV, the use of nivolumab as monotherapy is as effective a...
Read more
The study, funded by the Spanish Ministry of Science and Innovation, will analyse the usefulness of personal construct therapy in people aged 18-29 with mild to moderate symptoms of depression. It wil...
Read more
El estudio multicéntrico europeo MADIET fase IV ha demostrado que los pacientes de Fibrosis Pulmonar Idiopática (FPI) que siguen una dieta mediterránea sufren menos efectos adversos gastrointestina...
Read more
A study with the participation of IrsiCaixa and published in the journal Nature Medicine shows that starting the administration of an anti-HIV antibody and antiretroviral treatment at the same time wo...
Read more
Xeltis, a medtech company developing the most advanced polymer-based restorative cardiovascular devices, today announced very promising preliminary efficacy and safety results from one of the centers ...
Read more
Cuatro grupos de investigación realizan estudios pioneros sobre el dolor crónico. En el Día Mundial del Dolor que se celebró ayer 17 de octubre, las científicas y científicos de la UMH presentan...
Read more
Un equipo de investigadores liderado por el Consejo Superior de Investigaciones Científicas (CSIC) ha descubierto que la proteína SOS1 es necesaria para desarrollar leucemia mielogénica crónica, u...
Read more
Los investigadores del Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico de València, resaltan la importancia de la investigación clínica y traslacional en el Día Internacional ...
Read more
Clear path forward for ilofotase alfa as potential treatment in acute kidney injury, based on consistent improvement of renal parameters observed in REVIVAL and other clinical studies
Read more
The consumption of polyphenols in adolescents is associated with a better cardiovascular health, according to a collaborative research study which includes the participation of the University of Barce...
Read more
Mediante el uso de nanopartículas capaces de transformar un profármaco no activo en un fármaco activo, han dado un paso más en el desarrollo de un tratamiento efectivo. Como el fármaco sólo func...
Read more
Omomyc, a mini-therapeutic protein developed at the Vall d'Hebron Institute of Oncology (VHIO), has been shown in the preclinical phase in the laboratory to be able to enter cells and reach their nucl...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Investigadores del Cima Universidad de Navarra constatan que la combin...
